Transvenous pacing causing tamponade in patients receiving glycoprotein IIb/IIIa inhibitors for percutaneous coronary intervention

J Invasive Cardiol. 2007 Feb;19(2):E40-2.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Abciximab
  • Aged
  • Aged, 80 and over
  • Angioplasty
  • Antibodies, Monoclonal / adverse effects*
  • Antibodies, Monoclonal / therapeutic use
  • Atherectomy, Coronary / methods*
  • Cardiac Catheterization
  • Cardiac Pacing, Artificial / adverse effects*
  • Cardiac Pacing, Artificial / methods
  • Cardiac Tamponade / etiology*
  • Female
  • Femoral Vein
  • Humans
  • Immunoglobulin Fab Fragments / adverse effects*
  • Immunoglobulin Fab Fragments / therapeutic use
  • Male
  • Middle Aged
  • Pacemaker, Artificial / adverse effects
  • Platelet Glycoprotein GPIIb-IIIa Complex / antagonists & inhibitors*
  • Risk Factors
  • Thrombectomy / methods*
  • Tirofiban
  • Tyrosine / adverse effects
  • Tyrosine / analogs & derivatives*
  • Tyrosine / therapeutic use

Substances

  • Antibodies, Monoclonal
  • Immunoglobulin Fab Fragments
  • Platelet Glycoprotein GPIIb-IIIa Complex
  • Tyrosine
  • Tirofiban
  • Abciximab